06/23/18 Toll-like receptor 4 expression and functional signaling in human and murine B-cell lymphomas is strongly associated with response to treatment with the synthetic TLR4 agonist G100. AACR International Meeting Advances in Malignant Lymphoma. Abstract #158. View Poster. Posted in Publications
04/18/18 Component-specific qPCR assays for characterization and identity testing of multigenome ZVex®, a dendritic cell-targeting lentiviral vector platform. American Association for Cancer Research (AACR) 2018 Annual Meeting. Abstract #5919. View poster. Posted in Publications
01/25/18 Effect of intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist G100 on a clinical response and CD4 T-cell response locally and systemically. 2018 ASCO-SITC Clinical Immuno-Oncology Symposium. Abstract #71. View Poster. Posted in Publications
01/23/18 Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial. npj Vaccines. January 2018. View Publication. Posted in Publications
01/12/18 TLR4 Agonist Glucopyranosyl Lipid A (GLA) Induces T-regulatory Cells and Suppresses Th2 Cytokines in PBMC from Cashew-Allergic Donors. Mechanisms, Prevention of, and Emerging Therapies for Food Allergy Conference 2017. View Poster. Posted in Publications
